The current financial score of Nutex Health Inc is 9.13. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 210.75M, representing a year-over-year decrease of 13.62%, while its net profit experienced a year-over-year decrease of 472.05%.
The current valuation score of Nutex Health Inc is 9.47. Its current P/E ratio is 13.18, which is 21.23% below the recent high of 15.98 and 153.70% above the recent low of -7.08.
The current earnings forecast score of Nutex Health Inc is 8.00. The average price target is 288.20, with a high of 325.00 and a low of 200.00.
The current price momentum score of Nutex Health Inc is 4.28. Currently, the stock price is trading between the resistance level at 214.34 and the support level at 168.68, making it suitable for range-bound swing trading.
The current institutional shareholding score of Nutex Health Inc is 3.00. The latest institutional shareholding proportion is 46.78%, representing a quarter-over-quarter increase of 29.61%.
The current risk assessment score of Nutex Health Inc is 4.93. The company's beta value is 0.26. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.